Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -17.42% vs -9.96% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -10.20% vs -14.56% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -18.02% vs -51.04% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -57.14% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Jiangsu Kanion Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -8.23% vs -11.32% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -17.42% vs -9.96% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -6.65% vs -26.17% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -10.20% vs -14.56% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -55.08% vs -29.39% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -18.02% vs -51.04% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -57.14% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






